FrancophonIA/ELRC3.0 huggingface dataset:
English: The use of Osigraft with a synthetic bone void filler may lead to a risk of increase in local inflammation, infection and occasional migration of the implanted materials and is therefore not recommended (see section 4.5).
Estonian: Osigraft'i kasutamine sünteetilise luuõõnsuse täiteainega võib kasvatada ohtu, et suureneb kohalik põletik, infektsioon ja implanteeritud materjalide juhuslik ränne ning on seetõttu ebasoovitav (vt lõik
English: Interaction with other medicine
Estonian: Koostoime teise ravimiga
English: The active substance is eptotermin alfa (a recombinant human Osteogenic protein 1 produced in a recombinant Chinese hamster ovary (CHO) cell line).
Estonian: Toimeaine on alfaeptotermiin, rekombinantne inimese osteogeenne valk, mida valmistatakse hiina hamstri munasarja rakuliinist.
English: DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION
Estonian: ESMASE MÜÜGILOA VÄLJASTAMISE/MÜÜGILOA UUENDAMISE KUUPÄEV Esmase müügiloa väljastamise kuupäev: 18.05.2001
English: Women of child-bearing potential should inform their surgeon of the possibility of pregnancy before undergoing treatment with Osigraft.
Estonian: Fertiilses eas naised peaksid enne Osigraft-ravi saamist oma kirurgi võimalikust rasedusest teavitama.
English: This group of medicines cause new bone to grow at the location where the surgeon has placed (implanted) it. Osigraft is implanted in adult patients with fractures of the tibia which have failed to heal for at least 9 month duration in cases where treatment with autograft (transplanted bone from your hip) has failed or should not be used.
Estonian: Osigraft'i implanteeritakse täiskasvanud patsientidele, kelle sääreluumurd ei ole paranenud vähemalt 9 kuu jooksul, juhul kui eelnev ravi autograftiga (puusalt võetud luu siirdamine) on ebaõnnestunud või selle kasutamine ei ole võimalik.
English: Antibodies to eptotermin alfa were found in sera from pooled foetal and umbilical cord blood at levels that correlated to that of the maternal blood.
Estonian: Alfaeptotermiini antikehi leiti analüüsitud loodete ja nabanööri verest kontsentratsioonis, mis korreleerusid kontsentratsiooniga ema veres.
English: Each vial contains 3.3 mg of eptotermin alfa* *Produced in Chinese hamster ovary (CHO) cells by recombinant DNA technology For a full list of excipients, see section 6.1.
Estonian: KVALITATIIVNE JA KVANTITATIIVNE KOOSTIS Iga viaal sisaldab 3,3 mg alfaeptotermiini* * Toodetud rekombinantse DNA tehnoloogia abil hiina hamstri munasarja (CHO) rakukultuurist.
English: Antibodies to OP-1 protein were detected in 66% of patients in the tibial non-union study following the administration of eptotermin alfa.
Estonian: Sääreluu dekonsolidatsiooni uuringus tekkis alfaeptotermiini manustamise järgselt OP-1 valgu antikehasid 66% patsientidest.
English: An immune response to Osigraft should be considered and appropriate tests for the presence of antibodies in serum should be performed in cases where an immune-mediated undesirable effect is suspected, including cases where the product is ineffective.
Estonian: Juhtudel, kui kahtlustatakse ebasoovitavaid toimeid immuunsüsteemile, samuti juhul kui Osigraft on ebaefektiivne, tuleb kaaluda immuunreaktsiooni võimalust ravimpreparaadile ning teostada asjakohased analüüsid antikehade määramiseks seerumis.
English: What Osigraft looks like and contents of the pack Osigraft is supplied as white to off-white powder packaged in an amber coloured glass vial (pack size of 1) within a blister pack, comprised of a plastic tray and lid, in a carton.
Estonian: Osigraft'i tarnitakse valge kuni määrdunudvalge kuiva pulbrina merevaiguvärvi klaasviaalis (pakendis 1 viaal), mis on pakendatud plastalusest ja kaanest koosnevasse blisterpakendisse ja karpi.
English: Using sterile technique, remove the vial from its packaging.
Estonian: Võtke viaal pakendist välja, kasutades steriilset tehnikat.
English: Fertility There is no evidence to suggest that eptotermin alfa alters fertility.
Estonian: Fertiilsus Alfaeptotermiini mõju kohta viljakusele tõendid puuduvad.
English: Osigraft 3.3 mg powder for suspension for implantation eptotermin alfa
Estonian: Osigraft 3,3 mg, pulber siirdamissuspensiooni valmistamiseks alfaeptotermiin
English: CONTENTS BY WEIGHT, BY VOLUME OR BY UNIT
Estonian: PAKENDI SISU KAALU, MAHU VÕI ÜHIKUTE JÄRGI 3,3 mg
English: After reconstitution, the single use suspension for implantation should be used immediately.
Estonian: Valmissegatud ühekordselt kasutatavat lahust tuleb implantaadina koheselt kasutada.
English: Close soft tissues around the defect containing the product using suture material of choice.
Estonian: Sulgege pehmed koed ravimpreparaati sisaldava defekti ümber, kasutades vabalt valitud haavaniiti.
English: Powder in a glass vial (Type 1, borosilicate) sealed with a stopper (butyl rubber) and a crimp cap (aluminium).
Estonian: Pulber klaasviaalis (I tüüpi borosilikaat), millel on kork (butüülkummi) ja korgikate (alumiinium).
English: eptotermin alfa
Estonian: alfaeptotermiin.
English: Any unused product or waste material should be disposed of in accordance with local requirements.
Estonian: NÕUETELE Kasutamata materjal tuleb hävitada koos kirurgiliste jäätmetega vastavalt kohalikele seadustele.
English: Use of Osigraft does not guarantee repair; additional surgery may be required.
Estonian: Osigraft'i kasutamine ei garanteeri paranemist; võib vaja minna täiendavat kirurgilist sekkumist.
English: - for vertebral (spine) fractures.
Estonian: - lülisamba (selgroo) murdude korral.
English: - when there are any tumours in the area of the non-union site.
Estonian: • mis tahes tuumor dekonsolidatsioonihäire koha naabruses;
English: - if you have active infection at the site of non-union (inflammation and drainage at the site of
Estonian: - kui teil on murrukohas äge infektsioon (põletik ja dreen vigastatud kohas) või äge süsteemne infektsioon.
English: 3.3 mg of eptotermin alfa
Estonian: TOIMEAINE(TE) SISALDUS 3,3 mg alfaeptotermiini
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION
Estonian: Bioloogilis(t)e toimeaine(te) tootja(te) nimi ja aadress
English: Use of Osigraft does not guarantee repair, additional surgery may be required.
Estonian: Osigraft'i kasutamine ei garanteeri paranemist, võib vaja minna täiendavat kirurgilist sekkumist.
English: However, use of Osigraft does not guarantee repair; additional surgery may be required.
Estonian: Osigraft'i kasutamine ei garanteeri siiski paranemist ning võib vaja minna täiendavat kirurgilist sekkumist.
English: Experience from controlled clinical trials is limited to stabilisation of tibial non-union site using concomitant intramedullary nailing.
Estonian: Kontrollitud kliiniliste uuringute kogemus piirdub luumurru kaasuva stabiliseerimise kohta intramedullaarse naelastamisega.
English: Irrigate as necessary prior to the implantation of Osigraft.
Estonian: MIDA ON VAJA TEADA ENNE OSIGRAFT'I KASUTAMIST
English: Administration
Estonian: Käitlemine
English: Post procedural tenderness (Tenderness)
Estonian: Protseduurijärgne valulikkus (valulikku)
English: - for treating non-union resulting from pathological (disease-related) fractures, metabolic bone
Estonian: - patoloogilistest (haiguslikest) murdudest, metaboolsetest luuhaigustest ja tuumoritest põhjustatud konsolidatsioonihäire raviks.
English: Osigraft eptotermin alfa
Estonian: RAVIMPREPARAADI NIMETUS JA MANUSTAMISTEE Osigraft eptotermin alfa
English: - if you are an adolescent and your skeleton is not yet fully formed (still growing).
Estonian: - kui olete nooruk ja teie luustik pole veel täielikult välja arenenud (kasvab veel).
English: Justification for not including Braille accepted
Estonian: INFORMATSIOON BRAILLE' KIRJAS (PUNKTKIRJAS) Põhjendus Braille' kirja (punktkirja) mittelisamise kohta vastu võetud.
English: Osigraft 3.3 mg powder for suspension for implantation
Estonian: RAVIMPREPARAADI NIMETUS Osigraft 3,3 mg pulber siirdamissuspensiooni valmistamiseks
English: The reconstituted product is administered by direct surgical placement at the non-union site in contact with the prepared bone surface.
Estonian: Valmissegatud ravimpreparaat manustatakse vahetu kirurgilise paigaldamise teel konsolideerumishäire kohale kontakti ettevalmistatud luupinnaga.
English: Osigraft 3.3 mg powder for suspension for implantation.
Estonian: RAVIMPREPARAADI NIMETUS Osigraft 3,3 mg pulber siirdamissuspensiooni valmistamiseks.
English: common (affects 1 to 10 users in 100) uncommon (affects 1 to 10 users in 1,000) rare (affects 1 to 10 users in 10,000) very rare (affects less than 1 user in 10,000) not known (frequency cannot be estimated from the available data
Estonian: • aeg-ajalt (esineb 1-10 kasutajal 1000st)
English: VIAL
Estonian: MUU
English: have known autoimmune disease, including rheumatoid arthritis, systemic lupus erythematosus, scleroderma, Sjögren's syndrome and dermatomyositis/polymyositis; have active infection at the site of non-union or active systemic infection; have inadequate skin coverage and vascularity of the non-union site; have vertebral fractures; have a non-union resulting from pathological fractures, metabolic bone disease or tumours; have any tumour in the vicinity of the non-union site; are receiving chemotherapy, radiation treatment or immunosuppression;
Estonian: • teadaolev autoimmuunne haigus, sealhulgas reumatoidartriit, süsteemne erütematoosne luupus, skleroderma, Sjögreni sündroom ja dermato-/polümüosiit;
English: FOIL FOR THE BLISTER PACK (OUTER) FOR THE VIAL
Estonian: MINIMAALSED NÕUDED, MIS PEAVAD OLEMA VÄIKESEL VAHETUL SISEPAKENDIL VIAALI (VÄLIMISE) BLISTERPAKI FOOLIUM
English: This medicine should not be used after the expiry date which is printed on the carton and the blister.The expiry date refers to the last day of that month.
Estonian: Kõlblikkusaeg viitab kuu viimasele päevale.
English: Post procedural swelling (Swelling)
Estonian: • erüteem (nahapunetus)
English: These are both normal and do not need to be removed
Estonian: Need on mõlemad normaalsed ja neid ei ole vaja eemaldada.
English: • Improve your physical function.
Estonian: • parandada teie füüsilist funktsiooni;
English: • If you have an active infection which your doctor thinks is important.
Estonian: • kui teil on aktiivne infektsioon, mis on teie arsti arvates oluline.
English: Justification for not including in Braille accepted.
Estonian: Põhjendus Braille' mitte lisamiseks aktsepteeritud.
English: Date of first authorisation: 16 January 2009 Date of latest renewal: 19 September 2013
Estonian: Müügiloa esmase väljastamise kuupäev: 16. jaanuar 2009 Müügiloa viimase uuendamise kuupäev: 19. september 2013
English: UNIFI-I included 961 patients.
Estonian: UNIFI-I hõlmas 961 patsienti.
English: Ask your doctor if you are not sure.
Estonian: Küsige oma arstilt, kui te ei ole kindel.
English: However, the physician should ensure appropriate follow-up of patients.
Estonian: Arst peab siiski tagama asjakohase patsientide jälgimise.
English: Regulation of CYP450 enzymes
Estonian: CYP450 ensüümide regulatsioon
English: Other medicines, vaccines and Stelara
Estonian: Muud ravimid, vaktsiinid ja Stelara
English: Always have the outer carton of the medicine with you, even if it is empty.
Estonian: Võtke endaga alati kaasa ravimi välispakend, isegi juhul kui see on tühi.
English: Efficacy data were collected and analyzed through week 8 for both studies.
Estonian: Efektiivsusandmed koguti ja analüüsiti mõlema uuringu 8. nädalal.
English: No dose recommendations can be made.
Estonian: Seetõttu ei saa mingeid annustamissoovitusi anda.
English: • If you are 65 years of age or over - you may be more likely to get infections.
Estonian: • Kui te olete 65-aastane või vanem - teil võib suurema tõenäosusega infektsioone esineda.
English: Also tell your doctor if you have recently been near anyone who might have tuberculosis.
Estonian: Samuti rääkige oma arstile, kui te olete hiljuti viibinud kellegagi koos, kellel võib olla tuberkuloos.
English: • Reduce the signs and symptoms of your disease.
Estonian: • vähendada teie haiguse nähte ja sümptomeid;
English: If you are the parent or caregiver who will give Stelara to a child, please read this information carefully.
Estonian: Kui te olete lapsevanem või hooldaja, kes manustab Stelara't lapsele, lugege seda teavet hoolikalt.
English: CDLQI of 0 or 1 indicates no effect on child's quality of life.
Estonian: CDLQI 0 või 1 näitab, et mõju lapse elukvaliteedile puudub.
English: • it is the right medicine
Estonian: • kas tegemist on õige ravimiga;
English: Do not use the medicine if it has been shaken strongly.
Estonian: Ärge kasutage ravimit, kui seda on tugevalt loksutatud.
English: Health-related quality of life
Estonian: Tervisega seotud elukvaliteet
English: • Wash your hands very well with soap and warm water
Estonian: • Peske oma käsi väga hoolikalt seebi ja sooja veega.
English: • It is important that the needle is always in the liquid.
Estonian: • On oluline, et nõel jääks alati vedeliku sisse.
English: This leaflet has been written for the person taking the medicine.
Estonian: See infoleht on kirjutatud ravimit saavale isikule.
English: Patients in these studies had a diagnosis of PsA for at least 6 months.
Estonian: Nendes uuringutes osalevatel patsientidel oli PsA diagnoos vähemalt 6 kuud.
English: The key efficacy results are shown in Table 6 below.
Estonian: Peamised efektiivsuse tulemusnäitajad on toodud alljärgnevas tabelis 6.
English: Serious outcomes have included respiratory failure and prolonged hospitalisation.
Estonian: Tõsiste tagajärgede hulka kuulusid hingamispuudulikkus ja pikenenud haiglaravi.
English: Get everything together that you need and lay out on a clean surface.
Estonian: Koguge kõik vajalikud vahendid kokku ja asetage need puhtale pinnale.
English: A TNFα antagonist and/or vedolizumab.
Estonian: ¥ TNFα antagonist ja/või vedolizumab.
English: Most were considered to be mild and did not necessitate discontinuation of study treatment.
Estonian: Enamik neist olid kerged ja nende puhul ei olnud vaja uuringuaegset ravi lõpetada.
English: • If you ever had an allergic reaction to Stelara.
Estonian: • Kui teil on kunagi esinenud allergilist reaktsiooni Stelara'le.
English: If these symptoms occur, appropriate therapy should be instituted.
Estonian: Kui need sümptomid tekivad, tuleb alustada asjakohast ravi.
English: Tell your doctor if you have any kind of infection that will not go away or keeps coming back.
Estonian: Öelge oma arstile, kui teil on mingi infektsioon, mis ei kao või tuleb korduvalt tagasi.
English: Clinical Remission, week 8
Estonian: Kliiniline remissioon, 8. nädal
English: No reduced efficacy was observed.
Estonian: Toime vähenemist ei ole täheldatud.
English: If you have a serious allergic reaction, your doctor may decide that you should not use Stelara again.
Estonian: Kui teil tekib tõsine allergiline reaktsioon, võib teie arst otsustada, et te ei tohi enam Stelara't kasutada.
English: There are no adequate data from the use of ustekinumab in pregnant women.
Estonian: Puuduvad adekvaatsed andmed ustekinumabi kasutamise kohta rasedatel.
English: If your doctor thinks you are at risk of tuberculosis, you may be given medicines to treat it.
Estonian: Kui teie arst arvab, et teil on risk nakatuda tuberkuloosi, võidakse teile anda tuberkuloosivastaseid ravimeid.
English: At the start of treatment, your healthcare provider will assist you with your first injection.
Estonian: Ravikuuri alguses aitab teie tervishoiutöötaja teil esimest süstet teha.
English: Clinical Remission*
Estonian: Kliiniline remissioon*
English: Ustekinumab may have the potential to increase the risk of infections and reactivate latent infections.
Estonian: Ustekinumabil on potentsiaal suurendada infektsioonide riski ja reaktiveerida latentseid infektsioone.
English: Let the vial stand for about half an hour.
Estonian: Laske viaalil ligikaudu pool tundi seista.
English: Take the vial(s) out of the refrigerator.
Estonian: Võtke viaali(d) külmkapist välja.
English: Endoscopic Normalization
Estonian: Endoskoopiline normaliseerumine
English: Your doctor may decide that you should not use Stelara until the infection goes away.
Estonian: Teie arst võib otsustada, et te ei tohi Stelara't kasutada seni, kuni infektsioon on taandunud.
English: This effect was driven by PsA Study 1.
Estonian: Seda efekti andis edasi PsA uuring 1.
English: • Stelara 130 mg concentrate for solution for infusion is given in a hospital or clinic and patients should not need to store or handle it.
Estonian: • Stelara 130 mg infusioonilahuse kontsentraati manustatakse haiglas või kliinikus ning patsiendil ei ole tarvis seda säilitada ega käsitleda.
English: Chemical and physical in-use stability has been demonstrated for 8 hours at 15-25°C.
Estonian: Ravimi kasutusaegne keemilis-füüsikaline stabiilsus on tõestatud 8 tunni jooksul temperatuuril 15°C…25°C.
English: Improvement has been reported after discontinuation of ustekinumab and also, in some cases, administration of corticosteroids.
Estonian: Teatati seisundi paranemisest pärast ustekinumabi manustamise lõpetamist ning mõnedel juhtudel ka kortikosteroidide manustamisest.
English: It should be administered over at least one hour.
Estonian: Seda manustatakse vähemalt ühe tunni jooksul.
English: The improvement was sustained through week 28.
Estonian: Paranemine püsis nädalal 28.
English: Efficacy results presented for UNIFI-I and UNIFI-M were based on central review of endoscopies.
Estonian: UNIFI-I ja UNIFI-M puhul näidatud efektiivsustulemused põhinesid endoskoopiatulemuste kesksel läbivaatusel.
English: CDLQI of 0 or 1
Estonian: CDLQI 0 või 1
English: These treatments may also weaken part of the immune system.
Estonian: Need ravimeetodid võivad samuti nõrgestada osa immuunsüsteemist.
English: Radiographic Response
Estonian: Radioloogiline vastus
English: Talk to your doctor if you are on a low salt diet.
Estonian: Rääkige oma arstile, kui te olete piiratud soolasisaldusega dieedil.
English: Improvement in health-related quality of life was generally maintained during the extension through week 92.
Estonian: Tervisega seotud elukvaliteedi paranemine püsis uuringu jätkufaasis üldjuhul 92. nädalani.
English: The induction studies included 1409 (UNITI-1, n = 769; UNITI-2 n = 640) patients.
Estonian: Sissejuhatava ravi uuringutes osales 1409 patsienti (UNITI-1, n = 769; UNITI-2 n = 640).
English: Push it slowly and evenly, keeping the skin gently pinched
Estonian: Vajutage seda aeglaselt ja ühtlaselt, hoides nahka endiselt sõrmede vahel.
English: • If the seal is broken.
Estonian: • kui sulgur on katki.
English: • If you know, or think that it may have been exposed to extreme temperatures (such as accidentally frozen or heated).
Estonian: • kui te teate või arvate, et ravimit on hoitud äärmuslikel temperatuuridel (nt kogemata külmutatud või kuumutatud);
English: Your doctor will decide when you should receive your next dose.
Estonian: Teie arst otsustab, millal peate saama järgmise annuse.
English: Immunosuppressants like ustekinumab have the potential to increase the risk of malignancy.
Estonian: Immunosupressantidel nagu ustekinumab on potentsiaal suurendada pahaloomuliste kasvajate riski.
English: Because there is a higher incidence of infections in the elderly population in general, caution should be used in treating the elderly.
Estonian: Kuna eakate patsientide populatsioonis on infektsioonide esinemissagedus üldiselt suurem, tuleb eakate ravis kasutada ravimit ettevaatusega.
English: The basis for this analysis was that at least 100 patients (> 5% of the studied population) were treated concomitantly with these medicinal products for at least 90% of the study period.
Estonian: See analüüs põhines vähemalt 100 patsiendi andmetel (> 5% uuritud populatsioonist), kes said samaaegselt neid ravimeid vähemalt 90% ulatuses uuringu ajast.
English: Stelara belongs to a group of medicines called ‘immunosuppressants'.
Estonian: Stelara kuulub ravimite rühma, mida nimetatakse immunosupressantideks.
English: Approximately 50% of patients continued on stable doses of MTX (≤ 25 mg/week).
Estonian: Umbes 50% patsientidest jätkas MTX-i stabiilsete annustega (< 25 mg nädalas).
English: In order to improve the traceability of biological medicinal products, the tradename and the batch number of the administered product should be clearly recorded.
Estonian: Et parandada bioloogiliste ravimpreparaatide kasutamise jälgitavust, tuleb manustatud preparaadi nimetus ja partii number selgelt dokumenteerida.
English: PGA = Physician Global Assessment
Estonian: PGA = arsti üldhinnang (Physician Global Assessment)
English: • If you have ever had any type of cancer - this is because immunosuppressants like Stelara weaken part of the immune system.
Estonian: • Kui teil on kunagi olnud mingit tüüpi kasvajaid, sest immunosupressandid nagu Stelara nõrgestavad teatud osa immuunsüsteemist.
English: Concomitant use of immunomodulators did not have a significant impact on ustekinumab disposition.
Estonian: Immunomodulaatorite samaaegne kasutamine ei mõjutanud oluliselt ustekinumabi jaotumist.
English: Instructions for dilution:
Estonian: Juhised lahjendamiseks:
English: Biotransformation The exact metabolic pathway for ustekinumab is unknown.
Estonian: Biotransformatsioon Ustekinumabi täpne metaboolne rada ei ole teada.
English: STELARA does not contain preservatives; therefore any unused medicinal product remaining in the vial and the syringe should not be used.
Estonian: STELARA ei sisalda säilitusaineid; seetõttu ei tohi viaali või süstlasse jäänud kasutamata ravimit kasutada.
English: However, if you stop, your symptoms may come back.
Estonian: Samas võivad ravi katkestamisel sümptomid tagasi tulla.
English: Similarly, significant improvements were seen in Psoriasis Study 2 at week 4 and 12, which were sustained through week 24.
Estonian: Sarnaseid märkimisväärseid paranemisi nähti ka psoriaasi uuringus 2 nädalatel 4 ja 12, mis püsisid ka nädalal 24.
English: In these patients, 45 mg was also shown to be efficacious.
Estonian: Neil patsientidel oli efektiivne ka 45 mg annus.
English: Similar results were seen with each dose of ustekinumab.
Estonian: Sarnaseid tulemusi nähti ka iga ustekinumabi annuse manustamise korral.
English: However it is possible it may increase the chance of diseases related to a weaker immune system.
Estonian: Samas on võimalik, et see võib suurendada nõrgema immuunsüsteemiga seostatavate haiguste esinemissagedust.
English: Serious hypersensitivity reactions have been reported in the postmarketing setting, in some cases several days after treatment.
Estonian: Turuletulekujärgselt on teatatud rasketest ülitundlikkusreaktsioonidest, mõnel juhul mitu päeva pärast ravi.
English: PedsQL: The PedsQL Total Scale Score is a general health-related quality of life measure developed for use in children and adolescent populations.
Estonian: PedsQL: PedsQL on üldine tervisega seotud elukvaliteedi mõõde, mis on välja töötatud kasutamiseks lastel ja noorukitel.
English: Stelara will reduce the inflammation and other signs of the disease.
Estonian: Stelara vähendab põletikku ja teisi haigusnähte.
English: There is no apparent correlation between the presence of anti-ustekinumab antibodies and the occurrence of injection site reactions.
Estonian: Puudub ilmne seos ustekinumabivastaste antikehade olemasolu ja süstekoha reaktsioonide tekke vahel.
English: • If you have or have had a recent infection.
Estonian: • Kui teil on või on hiljuti olnud infektsioon.
English: Clinically important, active infection (e.g. active tuberculosis; see section 4.4).
Estonian: Kliiniliselt oluline, aktiivne infektsioon (nt aktiivne tuberkuloos; vt lõik 4.4).
English: If you do not respond well enough to these medicines, you may be given Stelara to:
Estonian: Kui teil ei teki piisavat ravivastust nendele ravimitele, võidakse teile anda Stelara't, et:
English: Pharmacotherapeutic group: Immunosuppressants, interleukin inhibitors, ATC code: L04AC05.
Estonian: Farmakoterapeutiline rühm: immunosupressiivsed ained, interleukiini inhibiitorid, ATC-kood: L04AC05.
English: Before administration, STELARA should be allowed to reach room temperature (approximately half an hour).
Estonian: Enne manustamist tuleb STELARA'l lasta seista kuni toatemperatuurini (ligikaudu pool tundi).